about
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammationStatins affect the presentation of endothelial chemokines by targeting to multivesicular bodiesExcessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza.Effects of long-chain monounsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats.A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient miceSuggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe).Bioavailability of n-3 fatty acids from n-3-enriched foods and fish oil with different oxidative quality in healthy human subjects: a randomised single-meal cross-over study.Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics.Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overloadSun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis.Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic strokeThe peripheral blood mononuclear cell microRNA signature of coronary artery disease.Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects.A complex interaction between Rickettsia conorii and Dickkopf-1--potential role in immune evasion mechanisms in endothelial cells.Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factorsIncreased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosisAn immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoe(-/-) mice.Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.CXCR4 blockade induces atherosclerosis by affecting neutrophil functionPlasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity.Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammationCoffee consumption and human health--beneficial or detrimental?--Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus.Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children.Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation.Inflammation in coronary artery disease: potential role for immunomodulatory therapy.Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation.Altered expression of genes involved in lipid metabolism in obese subjects with unfavourable phenotype.NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis.The complex role of T-cell-based immunity in atherosclerosis.Lack of Effects of a Single High-Fat Meal Enriched with Vegetable n-3 or a Combination of Vegetable and Marine n-3 Fatty Acids on Intestinal Peptide Release and Adipokines in Healthy Female SubjectsChemokines and cardiovascular risk.LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro.Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype.Atherosclerotic plaque stability--what determines the fate of a plaque?Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosisActivated platelets and atherosclerosis.Tumor necrosis factor superfamily molecules in acute coronary syndromes.Activin A in nonalcoholic fatty liver disease.
P50
Q28200764-935BA89F-1587-49F7-82A5-BF57CC89A226Q28729147-C8000F98-99FF-4449-9470-05B729D573B0Q30405122-B3C1267D-991A-4BFE-8445-D74C075FE59DQ32186980-630A4516-F812-43FC-BE7B-683E8DDEB34AQ33632677-25179CA1-001B-4461-87D3-07E208FA066CQ33715779-2CED4BD3-EB01-4ABE-9A0F-07BB015B5434Q33782239-A24845BA-1B26-40A2-BF73-6ED2C53988D7Q33791924-97D03CA4-4CE2-4361-B982-920E77703DDFQ33886486-730747FD-3485-4423-9F7D-4ED52C125711Q34025504-140B50EF-EF74-492E-8985-A02FDB5EFED8Q34103370-EB351269-77DD-45C6-ACE3-36BCC41A21A2Q34104103-FEE48D29-3FA1-4CE7-86C8-6FBD5C42A94EQ34126000-961CEE3F-BCD6-4547-9805-B93FD3ACC46CQ34426813-0FE24E9F-FE89-4214-AC3A-75FE13E6CE54Q34521175-9F7083F1-2B0A-48AC-A036-548C55591E4DQ34680900-2BFAAD80-7B32-419E-8CE8-1C18D7A6F958Q34983608-8372048B-952B-41E8-B7E7-6DFBABF86BAAQ35064061-49139E0E-746D-447A-8A82-680D5637B72FQ35406034-0453A9E4-DC6B-43DE-921A-1727B94E47E2Q35553707-8CAFE66C-1403-4B9D-8D88-159C4543BE56Q35565559-543196B5-C724-4BBD-86E7-DCF8E8A9B2EAQ35613674-123BA1D6-76CF-4541-8CBC-C9BB5DCAB81DQ35797015-4D4F0258-F4A4-4640-8528-23A84B33D02BQ36037001-4A092151-082C-4EE3-A54B-7571821E1403Q36245157-3B511818-5511-4F38-AB0C-9CADBC2AA392Q36283698-02FFDC4F-1D4D-44C0-8978-F29C58310181Q36314881-2E5885C6-3114-4570-A021-F300BFD23A85Q36752011-0BAC4B1B-80EE-4600-BB63-488CF2722FDBQ36947539-95F5F604-231E-4657-8BE1-C44B68C47F4BQ36956703-E45D9CA5-E2A4-446E-83F1-F0E51D2E7BF9Q37167783-CEC58C5E-E5B0-4410-88DC-299157EEB8B5Q37218440-AC4DEFED-28C7-4E93-894A-5FCFE012B6A6Q37231421-D5E4F58D-BBFE-46C8-BCD0-062C892A762EQ37242976-07AFE682-F2FF-4B62-9599-AF2EE9145B91Q37297571-789B9AAB-836A-4EB4-A145-A364B063F230Q37332292-3F14B72B-9D42-4552-A550-5545F85EDF07Q37439428-1D65D144-27A2-4366-9785-D26B880A35E1Q37786647-9728BEA4-6A68-4AF2-9DE8-5F62330DB722Q37805514-52F2BB5F-A3AD-46EC-A2D4-643C1B7858E4Q37847440-73E9A857-547B-4F61-BDFD-66E12AC7F366
P50
description
Noors onderzoekster
@nl
Norwegian researcher
@en
norsk forsker
@nb
taighdeoir Ioruach
@ga
name
Bente Halvorsen
@ast
Bente Halvorsen
@da
Bente Halvorsen
@de
Bente Halvorsen
@en
Bente Halvorsen
@es
Bente Halvorsen
@fr
Bente Halvorsen
@ga
Bente Halvorsen
@nb
Bente Halvorsen
@nl
Bente Halvorsen
@nn
type
label
Bente Halvorsen
@ast
Bente Halvorsen
@da
Bente Halvorsen
@de
Bente Halvorsen
@en
Bente Halvorsen
@es
Bente Halvorsen
@fr
Bente Halvorsen
@ga
Bente Halvorsen
@nb
Bente Halvorsen
@nl
Bente Halvorsen
@nn
prefLabel
Bente Halvorsen
@ast
Bente Halvorsen
@da
Bente Halvorsen
@de
Bente Halvorsen
@en
Bente Halvorsen
@es
Bente Halvorsen
@fr
Bente Halvorsen
@ga
Bente Halvorsen
@nb
Bente Halvorsen
@nl
Bente Halvorsen
@nn
P106
P21
P214
118148995991359752113
P27
P31
P496
0000-0002-6529-6485
P569
1964-01-01T00:00:00Z
P734
P735
P7859
viaf-118148995991359752113